[U.S. ANTI-DOPING AGENCY
]
Retesting Samples Using New Technology
In light of significant and ongoing advancements in
laboratory testing methods, USADA is retesting stored samples using the latest technologies, which empower more sensitive screening and longer detection windows. Under the 2015 World Anti-Doping Code, USADA can
retest stored urine and blood samples for up to 10 years, which helps to deter doping by ensuring that the few athletes who are not caught today, can and will be caught tomorrow. As routine practice, USADA stores thousands of urine and blood samples from athletes in Olympic, Paralympic, and Pan-American sport. In 2016, USADA retrieved and retested 81 urine samples
for prohibited growth hormone (GH) releasing factors like Growth Hormone Secretagogues (GHS) and GH-Releasing Peptides (GHRPs). The retested samples were from a range of athletes, including multiple elite athletes who represented the U.S. in the Rio Olympic and Paralympic Games. While none of the retested samples contained prohibited peptides, USADA now screens for many prohibited peptide substances as part of its routine screening protocol. USADA also retested 71 blood samples collected out-of-
competition before the 2012 London Olympic Games using the newly WADA-approved GH Biomarkers Test, which was developed by a Working Group established through the Partnership for Clean Competition. Unlike the former hGH Isoforms Test, the new GH Biomarkers Test extends
the detection window for exogenous GH-use by measuring two biomarkers: Insulin-like Growth Factor-I (IGF-I) and amino-terminal pro-peptide of type III collagen (P-III-NP). To further maximize detection and deterrence, USADA has incorporated the new GH Biomarkers Test into its routine blood testing. With the most advanced testing methods and a
comprehensive retesting program, USADA is helping to ensure that those who cheat are exposed, and that every athlete is given the opportunity to compete clean and win.
The U.S. Anti-Doping Agency (USADA) is the national anti-doping organization (NADO) in the United States for Olympic, Paralympic, Pan American, and Parapan American sport. The organization is charged with managing the anti-doping program, including in-competition and out- of competition testing, results management processes, drug reference resources, and athlete education for all United States Olympic Committee (USOC) recognized sport national governing bodies, their athletes, and events. Additionally, USADA contributes to the advancement of clean sport through scientific research and education & outreach initiatives focused on awareness and prevention.
USA Weightlifting & USADA Launch Lift Clean Initiative
USA Weightlifting is strengthening its commitment to clean competition and fair play by partnering with the U.S. Anti-Doping Agency (USADA) in launching the Lift Clean initiative.
Under Lift Clean, USA Weightlifting will expand the drug testing of athletes by both randomly and intelligently selecting local events throughout the year for USADA to perform doping screenings. USA Weightlifting and USADA will also strategically select events where doping is suspected by utilizing intelligence gathered from members of the weightlifting community who are willing to speak up
for clean sport. There will be no advanced notice given for which events will be tested under Lift Clean.
“Doping is cheating,” USA Weightlifting CEO Phil Andrews said. “We will work with athletes, coaches, clubs and meet directors in concert with USADA to ensure all of our athletes compete on a level playing field.”
Lift Clean, which rolls out January 1, 2017, will help USA Weightlifting toward its goal of a totally clean sport by identifying dishonest athletes at all levels of competition.
USAWEIGHTLIFTING.ORG << 15
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16